🩸 MYLeukaemia is a research project that aims to drive the future of cancer therapy beyond current patient trial-and-error treatments with the design of the next generation of functional ex vivo drug testing powered by cutting-edge Organ-on-Chip technology. 🚀

💉 With MYLeukaemia Organ-on-Chip platform we expect to advance knowledge on residual disease emergence in distinct leukaemia subtypes; and translate it into the development of new prognostic markers & therapeutic targets for Leukaemia eradication. 🎯

🌱 This entrepreneurship venture originated in an Foundation for Science and Technology (FCT)-funded R&D project and gathers scientific experts in the fields of both clinical and experimental leukaemia, cancer drug resistance, tissue engineering, biomaterials, microfluidics, proteomics & bioinformatics analysis in a cohesive and transdisciplinary approach taking on the challenge to drive functional precision medicine in Leukaemia care. 🧬

📢 This LinkedIn page is a space to share our research and our members’ knowledge with the open community. Keep an eye out for our upcoming posts! 👀

MYCancer

Hugo R. Caires

This department oversees the planning, execution, and completion of projects, ensuring they align with organizational goals.

MYCancer

Org chart

Teams

Project Management

Offices

MYCancer

Org chart

Teams

Project Management

Offices

Related companies